Free Trial

IBEX (IBEX) Competitors

IBEX logo
$28.92 -0.61 (-2.07%)
Closing price 04:00 PM Eastern
Extended Trading
$28.94 +0.02 (+0.09%)
As of 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IBEX vs. GDRX, FLYW, TASK, DFIN, NVEE, GB, STGW, UPBD, PLTK, and CRTO

Should you be buying IBEX stock or one of its competitors? The main competitors of IBEX include GoodRx (GDRX), Flywire (FLYW), TaskUs (TASK), Donnelley Financial Solutions (DFIN), NV5 Global (NVEE), Global Blue Group (GB), Stagwell (STGW), Upbound Group (UPBD), Playtika (PLTK), and Criteo (CRTO). These companies are all part of the "business services" industry.

IBEX vs. Its Competitors

GoodRx (NASDAQ:GDRX) and IBEX (NASDAQ:IBEX) are both small-cap business services companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, earnings, valuation, media sentiment, profitability and analyst recommendations.

In the previous week, IBEX had 4 more articles in the media than GoodRx. MarketBeat recorded 11 mentions for IBEX and 7 mentions for GoodRx. IBEX's average media sentiment score of 1.08 beat GoodRx's score of 1.01 indicating that IBEX is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
GoodRx
3 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
IBEX
9 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

63.8% of GoodRx shares are held by institutional investors. Comparatively, 81.2% of IBEX shares are held by institutional investors. 4.2% of GoodRx shares are held by company insiders. Comparatively, 6.7% of IBEX shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

GoodRx has a beta of 1.23, suggesting that its stock price is 23% more volatile than the S&P 500. Comparatively, IBEX has a beta of 0.77, suggesting that its stock price is 23% less volatile than the S&P 500.

IBEX has lower revenue, but higher earnings than GoodRx. IBEX is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GoodRx$792.32M1.89$16.39M$0.1043.00
IBEX$508.57M0.76$33.65M$2.2912.63

IBEX has a net margin of 6.93% compared to GoodRx's net margin of 4.33%. IBEX's return on equity of 25.51% beat GoodRx's return on equity.

Company Net Margins Return on Equity Return on Assets
GoodRx4.33% 8.86% 4.50%
IBEX 6.93%25.51%12.67%

GoodRx presently has a consensus price target of $5.80, suggesting a potential upside of 34.88%. IBEX has a consensus price target of $27.00, suggesting a potential downside of 6.64%. Given GoodRx's stronger consensus rating and higher possible upside, research analysts plainly believe GoodRx is more favorable than IBEX.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
GoodRx
0 Sell rating(s)
6 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.45
IBEX
0 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

IBEX beats GoodRx on 9 of the 16 factors compared between the two stocks.

Get IBEX News Delivered to You Automatically

Sign up to receive the latest news and ratings for IBEX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IBEX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IBEX vs. The Competition

MetricIBEXBUSINESS SVCS IndustryBusiness SectorNASDAQ Exchange
Market Cap$394.89M$5.78B$26.56B$9.77B
Dividend YieldN/A3.33%2.74%4.50%
P/E Ratio12.6328.7126.9926.38
Price / Sales0.761.81733.02110.80
Price / Cash9.2416.4225.6328.92
Price / Book3.004.686.196.58
Net Income$33.65M$155.37M$197.30M$265.84M
7 Day Performance-0.92%-3.18%-0.45%-0.07%
1 Month Performance4.22%2.79%10.32%5.83%
1 Year Performance67.75%53.32%34.73%17.88%

IBEX Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IBEX
IBEX
1.8494 of 5 stars
$28.92
-2.1%
$27.00
-6.6%
+71.3%$394.89M$508.57M12.6330,000News Coverage
Positive News
GDRX
GoodRx
4.2133 of 5 stars
$4.25
-6.8%
$5.80
+36.5%
-44.9%$1.58B$792.32M42.50950
FLYW
Flywire
2.5022 of 5 stars
$12.84
+0.2%
$13.71
+6.8%
-27.4%$1.57B$492.14M256.801,250
TASK
TaskUs
1.352 of 5 stars
$17.41
+0.2%
$17.40
-0.1%
+31.7%$1.56B$994.98M25.2348,200
DFIN
Donnelley Financial Solutions
3.2218 of 5 stars
$56.19
-0.1%
$71.33
+27.0%
-14.9%$1.55B$781.90M19.861,800News Coverage
Positive News
NVEE
NV5 Global
1.4786 of 5 stars
$22.56
flat
$25.67
+13.8%
N/A$1.51B$941.27M45.585,024
GB
Global Blue Group
1.2416 of 5 stars
$7.49
+0.1%
$6.00
-19.9%
+37.9%$1.49B$545.29M20.242,160
STGW
Stagwell
3.7445 of 5 stars
$5.61
-2.4%
$8.17
+45.7%
-21.6%$1.49B$2.84B12.2314,607Positive News
UPBD
Upbound Group
4.5194 of 5 stars
$25.21
-0.1%
$34.50
+36.9%
-23.7%$1.46B$4.32B14.1611,970Positive News
Analyst Upgrade
PLTK
Playtika
3.9905 of 5 stars
$3.72
-0.5%
$7.04
+89.1%
-51.0%$1.41B$2.55B15.503,500Positive News
CRTO
Criteo
3.8487 of 5 stars
$23.81
-1.6%
$40.00
+68.0%
-47.6%$1.40B$1.93B9.963,507News Coverage
Positive News

Related Companies and Tools


This page (NASDAQ:IBEX) was last updated on 9/2/2025 by MarketBeat.com Staff
From Our Partners